These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26587041)

  • 1. The Association of Ala133Ser Polymorphism and Methylation in Ras Association Domain Family 1A Gene With Unfavorable Prognosis of Hepatocellular Carcinoma.
    Feng Y; Li P; Liu Y; Sha Z; Feng L; Wang F; Mao Q; Xue W
    Hepat Mon; 2015 Oct; 15(10):e32145. PubMed ID: 26587041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.
    Bayram S
    Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between RASSF1A Ala133Ser polymorphism and cancer susceptibility: a meta-analysis involving 8,892 subjects.
    Bayram S
    Asian Pac J Cancer Prev; 2014; 15(8):3691-8. PubMed ID: 24870779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma.
    Abd-Elfatah G; Gad-Allah AN
    Immunol Lett; 2016 May; 173():36-41. PubMed ID: 26921475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of
    Yin G; Kong W; Liu X; Zheng S; Ying R; Shan Y
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1084-1098. PubMed ID: 35737461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma.
    Xu G; Zhou X; Xing J; Xiao Y; Jin B; Sun L; Yang H; Du S; Xu H; Mao Y
    Cancer Cell Int; 2020 Nov; 20(1):547. PubMed ID: 33292241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
    Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
    Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras Association Domain Family 1A Gene Promoter Methylation as a Biomarker for Chronic Viral Hepatitis C-related Hepatocellular Carcinoma.
    Abou Zeid AA; El-Sayed ET; Ahdy JK; Tawfik MR
    Cureus; 2023 Sep; 15(9):e45687. PubMed ID: 37868533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
    Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
    Xu B; Di J; Wang Z; Han X; Li Z; Luo X; Zheng Q
    Biochem Biophys Res Commun; 2013 Aug; 438(2):324-8. PubMed ID: 23891693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
    Hu L; Chen G; Yu H; Qiu X
    Hepatol Int; 2010 Jan; 4(1):423-32. PubMed ID: 20305761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
    Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
    Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).
    Niu H; Yang J; Yang K; Huang Y
    Medicine (Baltimore); 2017 Nov; 96(46):e8630. PubMed ID: 29145283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.